## Abstract Interferon alpha (IFN) has been the standard treatment for hepatitis C virus (HCV) infection. Using the kinetic curves of viral clearance, this study compared three treatment regimes based on IFN alone or in combination with Amantadine or Ribavirin to determine the mechanisms of action
โฆ LIBER โฆ
Development of novel antiviral therapies for hepatitis C virus
โ Scribed by Kai Lin
- Book ID
- 107636113
- Publisher
- SP Wuhan Institute of Virology, CAS
- Year
- 2010
- Tongue
- English
- Weight
- 526 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1674-0769
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Clearance kinetics of hepatitis C virus
โ
Francesco Torre; Rosella Giusto; Alessandro Grasso; Renata Brizzolara; Nadia Cam
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 102 KB
๐ 1 views
New antiviral therapies for chronic hepa
โ
Tatsuo Kanda; Fumio Imazeki; Osamu Yokosuka
๐
Article
๐
2010
๐
Springer-Verlag
๐
English
โ 387 KB
Antiviral therapy for hepatitis C
โ
Michelle M. Lipman; Scott J. Cotler
๐
Article
๐
2003
๐
Springer
๐
English
โ 350 KB
Triphasic decline of hepatitis C virus R
โ
Harel Dahari; Ruy M. Ribeiro; Alan S. Perelson
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 237 KB
๐ 1 views
When patients chronically infected with hepatitis C virus (HCV) are placed on antiviral therapy with pegylated interferon (IFN)-โฃ or IFN-โฃ plus ribavirin (RBV), HCV RNA generally declines in a biphasic manner. However, a triphasic decline has been reported in a subset of patients. A triphasic declin
Specific targeted antiviral therapy for
โ
Mark S. Sulkowski
๐
Article
๐
2007
๐
Springer
๐
English
โ 207 KB
Mechanisms of drug resistance to current
โ
Jean-Michel Pawlotsky
๐
Article
๐
2004
๐
Current Science Inc.
๐
English
โ 453 KB